07 Jan

Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More

The flow of biotech news is particularly heavy today, and for good reason. The annual J.P. Morgan Healthcare Conference, one of the biggest gatherings for the biopharmaceutical industry, kicked off today in San Francisco, and many companies, whether they’re speaking at the event or not, use this time to get their news out.

Xconomy is on the ground covering the conference this week. In the meantime, here’s a short roundup of biotech news announced today.

DEALS AND DATA

-Eli Lilly (NYSE: LLY) is paying $8 billion cash to acquire Loxo Oncology (NASDAQ: LOXO), a company developing drugs that target… Read more »

UNDERWRITERS AND PARTNERS

          

          

            

Leave a Reply